Ovarian cancer

• Phase I, double-blind, randomized, placebo-controlled study investigating the safety, tolerability and concentrations of the study product K … Not authorised
  2023-503909-11-00 1
• A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors Not authorised
  2024-519862-33-00 1 "Platinum-resistant ovarian cancer (PROC)"
• A study evaluating the safety, tolerability, pharmacokinetics, and activity of RO7566802 given alone and in combination with atezolizumab in … Pending
  2023-509266-38-00 1 "Locally Advanced or Metastatic Solid Tumors"
• The assessment of bevacizumab dose equivalence in ovarian cancer Pending
  2023-509659-15-00 6 "Patients with ovarian cancer, fallopian tube cancer, periton"
• A Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients with Recurrent O … Pending
  2024-516327-14-00 4
• A Study to Determine the Effectiveness of a Test Drug ([68Ga]BED003) for the Detection of Pancreatic, Colorectal, Gastric, Breast and Ovaria … Pending
  2025-521983-36-00 4 "Colorectal cancer (CRC), gastric cancer (GC), pancreatic duc"
• Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending
  2025-522748-42-00 5
• A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, a … Pending
  2025-523590-42-00 7 "Locally Advanced or Metastatic Solid Tumors"
• DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors Pending
  2025-523895-22-00 4 "Non-small cell lung cancer (NSCLC)"
• A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors Recruiting
  2024-519862-33-01 1 2026-05-18 "Advanced renal cell carcinoma (RCC)"
• A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting
  2023-508047-40-00 5 2026-04-30
• A clinical study to test MEN2501 in patients with treatment-resistant ovarian cancer Recruiting
  2025-524168-39-00 1 2026-04-13 "​​Platinum-Resistant ovarian cancer​"
• A Clinical Trial to Assess a New Anti-Cancer Treatment (called DSB2455) Given On Its Own in Patients with Advanced Malignancies Recruiting
  2023-508805-26-00 1 2024-10-23 "patients with active brain metastases, where the primary tum"
• A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 Recruiting
  2023-504445-31-00 4 2024-09-19 "Carcinoma, Head and Neck"
• A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors Recruiting
  2022-502654-14-00 4 2023-09-11 "Endometrial cancer"
• Evaluation of Niraparib alone compared to the combination of Niraparib and Bevacizumab in patients receiving chemotherapy for newly diagnose … Recruiting
  2024-516066-11-00 5 2022-08-31 "Patients with newly diagnosed, histologically confirmed, pri"
• A Phase 2 study of zanidatamab in patients with HER2-expressing tumors Recruiting
  2024-516551-41-00 4 2026-03-06 "Patients with HER2-expressing solid tumors"
• Phase 2 Study of INCB123667 in Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression Recruiting
  2025-521513-14-00 4 2026-02-10 "Ovarian Cancer"
• A Phase 1a/1b, Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity … Recruiting
  2025-523165-19-00 1 2026-02-10 "Advanced, metastatic or unresectable solid tumors"
• A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations with Intravenous Mirvetuximab Soravtansin … Recruiting
  2025-521606-18-00 4 2026-01-29 "Ovarian Cancer"
• A trial to learn how safe AZD5335 is and if a drug called itraconazole changes how AZD5335 moves through the body over time in adults with o … Recruiting
  2025-522731-34-00 3 2026-01-23 "Ovarian cancer Primary peritoneal cancer Fallopian tube canc"
• Trial of THEO-260 in Ovarian Cancer Patients (OCTOPOD) Recruiting
  2024-511236-27-00 7 2025-11-12 "High grade serous or endometroid ovarian cancer"
• Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Platinum Resistant Ovarian Cancer Recruiting
  2024-514822-21-00 5 2025-10-02 "Platinum-resistant Ovarian Cancer"
• Study of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer … Recruiting
  2024-516982-35-00 5 2025-09-11 "Ovarian Cancer"

Showing 1–24 of 82 trials